Urs H. Flueckiger has over 30 years of experience in senior management roles in the pharmaceutical industry. He has a Masters in Economics and has worked for Roche in various countries, including Switzerland, South Korea, the Philippines, and Saudi Arabia. His experience includes launching new drugs, managing country operations, and closing/divesting facilities. Currently he is the Chairman of TwentyTwelve AG, a fashion retail business in Basel.
Introduction to one of best medicine company Glaxo-smith-kline commonly known as GSK. this presentation gives detail introduction about GSK functions and products. Also global strategies which company is using.
Introduction to one of best medicine company Glaxo-smith-kline commonly known as GSK. this presentation gives detail introduction about GSK functions and products. Also global strategies which company is using.
1. Curriculum Vitae
Name : Urs H. Flueckiger
Economist, Master Degree
Date of Birth : February 23, 1957
Nationality : Switzerland
Contact : Address: Falknerstrasse 35, 4001 Basel
☏ Mobile : +41 79 359 95 80
email : urs.flueckiger88@gmail.com
BUSINESS EXPERIENCE
Overall : Broad experience in total company management in the pharmaceutical sector:
Marketing, Finance, Human Resources, Manufacturing, Logistics, Clinical
Development, Regulatory Affairs. Excellent record in driving sales and profitability
in a sustainable manner.
Extensive experience in the pre-marketing and marketing of numerous prescription
products in the fields of oncology, virology, metabolism, anemia, dermatology, CNS
and anti-immune system.
Launch of a wide range of biotechnology products such as Mabthera, Herceptin,
Avastin, Pegasys and Mircera and making them market leaders in their therapeutic
segments.
Experience in handling acquisition, integration and divestment of businesses
related to the corresponding Roche affiliates with the aim of creating efficiencies
and synergies, Examples: Boehringer Mannheim, Syntex and Sara Lee
Pharmaceuticals. Sale of dermatological product line to Stiefel Singapore.
Closure and divestment of the company factory in Ansong, Korea in 2006.
Extensive experience in working in a unionized environment in Korea and the
Philippines.
Active member in a variety of industry organizations as part of shaping the
regulatory, business and healthcare framework in many countries.
Feb 2012 – present TwentyTwelve AG, Basel, Switzerland
Fashion Retail Business, Import and Sale of International Brands
Chairman
Jan 2010 – Dec 2013 F. Hoffmann-La Roche Ltd., Basel, Switzerland
General Manager, Management Center Central Asia
based in Basel
Sales 2013: US$ 150 Mio. Growth 2010 -2013: 38% Headcount: 180
Directed and supervised as Regional Manager the Affiliates and Representative
Offices in 12 countries (Belarus, Ukraine, Moldova, Georgia, Armenia, Azerbaijan,
Kazakhstan, Uzbekistan, Kyrgyzstan, Turkmenistan, Tajikistan, Mongolia)
2. Designed and implemented organizational structures and developed the business
in these CIS countries to a higher level. Emphasis is on enlarging the retail and
distribution part of the business and the expansion of the government tender sales.
Country specific approach due to varying purchasing power. Promising sales and
profit growth in the first year with 22% and 55% respectively.
Outlined clear priorities in which countries to set up fully structured affiliates, where
to maintain Representative Offices and where to outsource the business to local
distributors.
May 2003 – Dec 2009 Roche Korea Co., Ltd., Seoul, South Korea
President & General Manager
Sales 2009 : US$ 310 Mio. Growth 2003-2009: 370% Headcount : 220
Successfully managed the overall activities of Roche Korea in the sales of
pharmaceutical products Achieved the business turnaround from declining sales in
2002/03 to above market sales growth and commensurate improvement in
profitability. Established Roche as the leading company in oncology. Started clinical
research projects of marketed and pipeline products (more than 40 Ph. III studies)
in key hospitals in Korea,
Maintained manufacturing at Ansong plant until 2006, and subsequently closed
and divested the factory to Daewoong Chemical Ltd, one of the largest Korean
pharmaceutical and chemical companies.
Successfully negotiated in 2008 with the Korean MOH a US$ 100 Mio contract for
the procurement of Tamiflu for the influenza pandemic stockpile program.
Made exploratory business trips to North Korea.
May 1993 – Apr 2003 Roche (Philippines) Inc., Manila, Philippines
General Manager
Sales 2002 : US$ 60 Mio. Headcount : 280
Successfully managed the overall activities of Roche Philippines in the sales of
pharmaceutical products, Toll manufacturing by Interphil Ltd., Manila
Lead Roche to the top three MNC’s in the Philippines with primary care products.
Apr 1990 – May 1993 Roche Saudi Arabia, Jeddah
Country Manager
Sales 1992: US$ 40 Mio, Headcount: 45
Guided the local organization in the sales of Rx and OTC products in cooperation
with the agent Saudi Import Company Ltd.
Achieved the turnaround from declining sales to above market growth.
Jan 1990 – Mar 1990 Roche (Philippines) Inc.
Assistant to the General Manager
Introduction to the local business environment for the incoming General Manager
3. Apr 1989 – Dec 1989 Asia Pacific Regional Product Executive for TILCOTIL (tenoxicam)
based in Manila
Preparation and guidance for the product launch in APAC. Monitoring of sales
performance in cooperation with local teams.
May 1987 – Apr 1989 Roche (Philippines) Inc., Manila
Marketing Planning Manager
Responsible for the product management team for the complete Roche product
portfolio
May 1985 – Apr 1987 F. Hoffmann-La Roche Ltd. –Mississauga, Canada
Product Manager
Product management for Antibiotics and CNS Products (Anti-Parkinson)
Feb 1985 – May 1985 Sauter, AG, Geneva, Switzerland, Subsidiary of F. Hoffmann-La Roche LTD.
Training in OTC Product Management
Mar 1983 – Feb 1985 F. Hoffmann-La Roche Ltd., Basel, Switzerland
Marketing Trainee,
Introduction to sales, market research, product management, medical activities and
event organization
INTERNSHIPS
May – Sep 1981 Internship with Austrian Airlines, Vienna, Austria
May – Oct 1980 Internship with IBM, Basle Branch, Switzerland
MEMBERSHIPS
Jun 2004 – Dec 2009 Swiss-Korean Business Council (SKBC), Seoul , Korea
Board Member
2005 -2009 Chairman
Jun 2004 – Dec 2009 Korean Research-based Pharmaceutical Industry Association (KRPIA), Seoul, Korea
Board Member
Chairman of the Market Access Committee
Chairman of the HR Committee
2003 – 2009 European Union Chamber of Commerce Korea (EUCCK), Seoul, Korea
Member of the Pharmaceutical Committee
1996 – 2001 European Chamber of Commerce (ECCP), Manila, Philippines
Board Member
1998 – 2001 Vice President /Treasurer
1998 – 2003 Pharmaceutical & Healthcare Association of the Philippines (PHAP),Manila,
Philippines
Board Member
Member of the following committees :
o Anti-Counterfeit Products – Chairman
o Ethics Code
1993 – 2003 Rotary Club of Makati, Philippines
4. EXECUTIVE COURSES
2007 Engage Course, Buonas, IMD, Switzerland
2004 Media training, Hong Kong
2001 Insights Course – London Business School, London, UK
2000 Rising to the Leadership Challenge II – London Business School, London, UK
1998 Rising to the Leadership Challenge I – INSEAD Fontainebleau, France
1995 Roche Executive Development Course – Thun, Switzerland
1994 Roche Course for non-Finance Managers, Hergiswil, Switzerland
1992 Roche International Manager Course – Hergiswil, Switzerland
1991 ISSR Pilot Seminar – Nicosia / Cyprus
1991 Kotler on Marketing – The Queen Elizabeth II Conference Centre, London, UK
1990 International School of Sales, Heinz Goldmann, Inc.
International Business Negotiations, Divonne Les Bains, France
EDUCATION
1977 – 1983 University of Basel, Switzerland
Masters in Economics, Finance & Marketing
LANGUAGES
German (native), English (fluent), French (advanced), Italian (basic), Russian
(basic)